增强三维自旋回波T1加权序列在3.0T脑MRI多发性硬化病灶检测中优于三维梯度回波T1加权序列
这项单中心前瞻性研究纳入158例多发性硬化患者,在3.0T脑MRI随访中比较增强三维梯度回波T1加权与三维涡轮自旋回波T1加权序列对强化病灶的检出。三维涡轮自旋回波T1加权序列检出强化病灶的患者数和人均病灶数均显著多于三维梯度回波T1加权序列,且对比度与对比噪声比更高。
要点
- 3.0T增强脑MRI随访多发性硬化时,三维涡轮自旋回波T1加权检出强化病灶显著多于三维梯度回波T1加权。
- 三维涡轮自旋回波T1加权每位患者平均强化病灶数高于三维梯度回波T1加权,阅片时需注意序列选择对病灶计数的影响。
- 两序列观察者间一致性均优,三维涡轮自旋回波T1加权κ=0.96,三维梯度回波T1加权κ=0.92。
核心结论
- 在3.0T下,增强三维涡轮自旋回波T1加权较三维梯度回波T1加权可检出显著更多的强化病灶,作者认为需要对多发性硬化患者行增强检查时应使用该序列。
研究设计与样本
- 单中心前瞻性研究,纳入2017年8月至2021年4月因随访行3.0T脑MRI的多发性硬化患者158例(平均年龄40±11岁,95例女性),增强三维梯度回波T1加权与三维涡轮自旋回波T1加权按随机顺序采集。
诊断标准与关键数值
- 以第三位专家神经放射科医师建立的参考标准比较,读者1在三维涡轮自旋回波T1加权与三维梯度回波T1加权上检出至少1个强化病灶的患者分别为61/158(38.6%)与48/158(30.4%),读者2分别为60/158(38.6%)与47/158(29.7%),P<0.001。
临床应用与阅片要点
- 作者认为,对需要增强检查的多发性硬化患者应使用增强三维涡轮自旋回波T1加权序列。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Using reliable contrast-enhanced T1 sequences is crucial to detect enhancing brain lesions for multiple sclerosis (MS) at the time of diagnosis and over follow-up. Contrast-enhanced 3D gradient-recalled echo (GRE) T1-weighted imaging (WI) and 3D turbo spin echo (TSE) T1-WI are both available for clinical practice and have never been compared within the context of this diagnosis.
PURPOSE: The aim of this study was to compare contrast-enhanced 3D GRE T1-WI and 3D TSE T1-WI for the detection of enhancing lesions in the brains of MS patients.
METHODS: This single-center prospective study enrolled patients with MS who underwent a 3.0 T brain MRI from August 2017 to April 2021 for follow-up. Contrast-enhanced 3D GRE T1-WI and 3D TSE T1-WI were acquired in randomized order. Two independent radiologists blinded to all data reported all contrast-enhanced lesions in each sequence. Their readings were compared with a reference standard established by a third expert neuroradiologist. Interobserver agreement, contrast ratio, and contrast-to-noise ratio were calculated for both sequences.
RESULTS: A total of 158 MS patients were included (mean age, 40 ± 11 years; 95 women). Significantly more patients had at least 1 contrast-enhanced lesion on 3D TSE T1-WI than on 3D GRE T1-WI for both readers (61/158 [38.6%] vs 48/158 [30.4%] and 60/158 [38.6%] vs 47/158 [29.7%], P < 0.001). Significantly more contrast-enhanced lesions per patient were detected on 3D TSE T1-WI (mean 2.47 vs 1.56 and 2.56 vs 1.39, respectively, P < 0.001). Interobserver agreement was excellent for both sequences, κ = 0.96 (confidence interval [CI], 0.91-1.00) for 3D TSE T1-WI and 0.92 (CI, 0.86-0.99) for 3D GRE T1-WI. Contrast ratio and contrast-to-noise ratio were significantly higher on 3D TSE T1-WI (0.84 vs 0.53, P < 0.001, and 87.9 vs 57.8, P = 0.03, respectively).
CONCLUSIONS: At 3.0 T, contrast-enhanced 3D TSE-T1-WI supports the detection of significantly more enhancing lesions than 3D GRE T1-WI and should therefore be used for MS patients requiring contrast-enhanced examination.
引用
- de Panafieu A, Lecler A, Goujon A, et al. Contrast-Enhanced 3D Spin Echo T1-Weighted Sequence Outperforms 3D Gradient Echo T1-Weighted Sequence for the Detection of Multiple Sclerosis Lesions on 3.0 T Brain MRI. Invest Radiol. 2022. PMID: 36729811. doi:10.1097/RLI.0000000000000937
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。